Curewell Capital Management LLC

ITEM 5 – FEES AND COMPENSATION

Curewell receives an annual management fee (“Management Fee”) from each Fund. Depending
on the Fund, the annual Management Fee ranges from 1% to 2% of the non-affiliated partners’
invested capital or committed capital, subject to the relevant Governing Documents. The
Management Fee is in addition to each investor’s capital commitments for Funds other than Fund
I and is payable quarterly in advance by each Fund. Installments of the Management Fee payable
for any period other than a full quarterly period are adjusted on a pro rata basis according to the
actual number of days in such period. In Funds other than Fund I, an additional one-time upfront
closing fee is payable to the Adviser pursuant to the Fund’s Governing Documents in its initial
capital call notice.

The relevant General Partner receives carried interest from each Fund generally equal to 20% of
the net profits of the Fund, depending on the Fund and whether certain return hurdles have been
achieved as described in the relevant Governing Documents. The carried interest is allocated to
the capital account of the relevant General Partner (or its affiliate) and is generally distributed by
each Fund after investors have received 100% of their capital contributions in respect of realized
investments (including expense contributions and Management Fees), subject to an annual
compounded return hurdle in some of the Funds (including Fund I), as further described in the
relevant Governing Documents.

Each General Partner is permitted, in its sole discretion, to reduce or waive all or a portion of the
Management Fee and other fees. Curewell is permitted to exempt certain “affiliated partner”
investors in the Funds from payment of all or a portion of Management Fees and/or carried interest,
including Curewell and any other person designated by Curewell such as “friends and family” of
Curewell, its personnel, Operations Group (as defined below) members and other service providers
(including suppliers, vendors, consultants, lenders, law firms (including Fund or transaction
counsel), and transaction service providers) and their respective affiliates, personnel and related
investment vehicles (together, “Service Providers”), or other investors as determined by the
General Partner based on commitment size or other strategic or relationship factors. Specific
information about the Management Fees and carried interests for each Fund is provided in each
Fund’s Governing Documents. Curewell retains flexibility to structure its compensation from
investors and expects in certain circumstances to agree to invoice an investor directly for
Management Fees or other compensation, rather than deducting such amounts from the investor’s
capital account(s).

Curewell is permitted to receive transaction fees, placement fees, monitoring fees, consulting fees,
directors’ fees and other similar fees (“Transaction Fees”) in connection with any Fund investment
or prospective investment, in each case net of certain expenses (including those described below)
as set forth in the Fund’s Governing Documents. Generally, the Management Fee will be reduced

by an amount equal to the relevant Fund’s portion of Transaction Fees attributable to Partners not
designated as “affiliated partners” by the General Partner. “Transaction Fees” do not include, (i)
any amount received by the relevant General Partner, the Operations Group or other persons from
a portfolio company, prospective portfolio company or other person (a) as reimbursement for
expenses directly related to such portfolio company or prospective portfolio company, (b) as
payment for services provided to any portfolio company or prospective portfolio company in the
ordinary course of such company’s business, (c) as compensation for services provided by the
General Partner, members of the Operations Group or other persons as an employee of or in a
similar capacity for such portfolio company or prospective portfolio company (including via
secondment of personnel of the General Partner or its affiliates or members of the Operations
Group) or (d) as fees, expenses or compensation (including amounts set forth in “Operations
Group” below) paid to, or received by or in respect of, members of the Operations from the Fund
or a portfolio company or prospective portfolio company or (ii) any other fees or expenses
approved by the limited partner advisory board (“Advisory Board”) of the Fund. Various costs and
expenses will reduce Transaction Fees (and therefore such amounts will not reduce the
Management Fee), including out-of-pocket costs and expenses (including travel expenses)
incurred by the General Partner or its affiliates in connection with any consummated or
unconsummated transaction or in connection with generating any such Transaction Fees.

Any Transaction Fees with respect to an investment or potential investment (including a
transaction not consummated) shall be allocated to the Fund (and offset against the Management
Fee as described above) only to the extent of the Fund’s relative ownership (or anticipated
ownership) of such investment or potential investment on a fully diluted basis. Accordingly, the
Fund will, in most cases, only benefit from the Management Fee reduction described above with
respect to its allocable portion of any such Transaction Fee and not the portion allocable to any
other person that holds an economic interest in (or, in the case of a transaction not consummated,
would have held an economic interest in) the applicable investment (including with respect to non-
control investments), including, without limitation, sellers or current or former portfolio company
management who have rolled their interests in the investment or reinvested proceeds or any other
equity-holder in an investment, as further described in “Item 8-Methods of Analysis, Investment
Strategies and Risk of Loss—Risk of Investment and Conflicts of Interest—Conflicts of Interest”
...

ITEM 7 – TYPES OF CLIENTS

Curewell provides investment advisory services to the Funds, which are pooled investment
vehicles organized and operating as private investment funds. The Funds include investment
partnerships or other investment entities formed under domestic or foreign laws and operated as
exempt investment pools under the Investment Company Act of 1940, as amended, and the rules
and regulations promulgated thereunder. Fund investors generally must meet minimum net worth
and other criteria as required by applicable federal securities laws and regulations, including
meeting the requirements to be deemed “accredited investors” (as defined in Regulation D under
the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder (the
“Securities Act”)) or “qualified purchasers” (as defined in Section 2(a)(51) of the Investment
Company Act) as required by the Fund’s Governing Documents. Admission to the Funds is not
open to the general public.

The minimum amount investors invest for participation in a Fund is set forth in the Fund’s offering
materials and varies from Fund to Fund, generally $5,000,000 for third-party investors, and is
subject to waiver by Curewell. Curewell has waived such minimum investment amounts in the
past and likely will waive such requirements under certain circumstances in the future.